论文部分内容阅读
目的探讨孟鲁司特钠联合阿奇霉素及布地奈德对治疗儿童支原体肺炎的临床疗效。方法选取我院2016年2月~2017年2月收治的患有支原体肺炎的儿童患者50例作为研究对象,按不同的治疗方法,分为观察组和对照组。其中对照组患儿25例,采用静脉滴注阿奇霉素治疗;观察组患儿25例,采用孟鲁司特钠联合阿奇霉素及布地奈德治疗。结果采用不同的治疗方法治疗后,观察组患者的临床疗效情况及治疗后发病率情况优于对照组,P<0.05,具有统计学意义。结论经临床观察研究发现,采用孟鲁司特钠联合阿奇霉素及布地奈德治疗儿童支原体肺炎具有高效、安全的优势,其疗效值得临床推广。
Objective To investigate the clinical efficacy of montelukast combined with azithromycin and budesonide in the treatment of children with mycoplasma pneumonia. Methods Fifty children with mycoplasmal pneumonia admitted from February 2016 to February 2017 in our hospital were selected as the research objects and divided into observation group and control group according to different treatment methods. 25 cases in control group were treated with intravenous azithromycin, 25 cases in observation group were treated with montelukast sodium combined with azithromycin and budesonide. Results After treatment with different treatments, the clinical efficacy and morbidity of the observation group were better than those of the control group (P <0.05), which were statistically significant. Conclusion Clinical observation found that the combination of montelukast sodium and azithromycin and budesonide in children with mycoplasma pneumonia has the advantages of high efficiency and safety, and its efficacy is worthy of clinical promotion.